These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 546874)

  • 1. High-performance liquid chromatographic determination of dihydralazine in human plasma.
    Waller AR; Chasseaud LF; Taylor T
    J Chromatogr; 1979 May; 173(1):202-7. PubMed ID: 546874
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid chromatographic determination of dihydralazine and hydralazine in human plasma and its application to pharmacokinetic studies of dihydralazine.
    Rouan MC; Campestrini J
    J Pharm Sci; 1985 Dec; 74(12):1270-3. PubMed ID: 4087193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of apparent dihydralazine in plasma by gas--liquid chromatography and electron-capture detection.
    Degen PH; Brechbühler S; Schneider W; Zbinden P
    J Chromatogr; 1982 Dec; 233():375-80. PubMed ID: 7161351
    [No Abstract]   [Full Text] [Related]  

  • 4. [The quantitative determination of dihydralazine and selected metabolites in man].
    Schneider T; Siegmund W; Zschiesche M; Kallwellis R
    Pharmazie; 1988 Oct; 43(10):704-6. PubMed ID: 3212018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the kinetics and distribution of dihydralazine in pregnancy.
    Franke G; Pietsch P; Schneider T; Siegmund W; Grabow D; Schütz H
    Biol Res Pregnancy Perinatol; 1986; 7(1):30-3. PubMed ID: 3955125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects.
    Waller AR; Chasseaud LF; Taylor T; Darragh A; O'Kelly DA
    Biopharm Drug Dispos; 1979; 1(2):59-64. PubMed ID: 552862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydralazine and dihydralazine on connective tissue and binding to serum protein.
    Blumenkrantz N; Christiansen AH; Asboe-Hansen G
    Scand J Rheumatol; 1979; 8(3):177-83. PubMed ID: 227048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The quantitative identification of metabolites of dihydralazine in the human].
    Schneider T; Siegmund W; Zschiesche M; Kallwellis R; Scherber A
    Pharmazie; 1988 Jan; 43(1):33-6. PubMed ID: 3375299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine.
    Williams GM; Mazue G; McQueen CA; Shimada T
    Science; 1980 Oct; 210(4467):329-30. PubMed ID: 7423193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazine.
    Haegele KD; Skrdlant HB; Talseth T; McNay JL; Shepherd AM; Clementi WA
    J Chromatogr; 1980 Jan; 187(1):171-9. PubMed ID: 7358814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydralazine sulfate analysis using 2-methyl-o-nitropyridine-6-carboxaldehyde.
    Youssef AF; Ibrahim SA; Elshabouri SR
    J Pharm Sci; 1977 Jan; 66(1):116-8. PubMed ID: 833726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method development for dihydralazine with HPLC-MS/MS--an old but tricky substance in human plasma.
    Mascher DG; Tscherwenka W; Mascher HJ
    J Pharm Biomed Anal; 2007 Jan; 43(2):631-45. PubMed ID: 16950590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dihydralazine on the renal kallikrein-kinin system of the rat.
    Bönner G; Beck D; Deeg M; Marin-Grez M; Gross F
    Eur J Pharmacol; 1982 Feb; 78(2):219-23. PubMed ID: 6918300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spectrophotometric analysis of the multicomponent system: dihydralazine sulfate, hydrochlorothiazide and reserpine].
    Beyrich T; Feldmeier HG; Herberg H
    Pharmazie; 1989 Jan; 44(1):36-9. PubMed ID: 2727027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the acetylator phenotype for the clinical use of dihydralazine.
    Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydralazine therapy and acetylator phenotype.
    Iisalo E; Laine T; Lehtonen A; Sellman R
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydralazine hepatitis: report of a case and review of the literature.
    Pariente EA; Pessayre D; Bernuau J; Degott C; Benhamou JP
    Digestion; 1983; 27(1):47-52. PubMed ID: 6884586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clonidine and dihydralazine on atrial natriuretic factor and cGMP in humans.
    Wehling M; Müller T; Heim JM; Lorenz R; Witzgall H; Weil J; Gerzer R
    J Appl Physiol (1985); 1989 Sep; 67(3):938-44. PubMed ID: 2551880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure response and renin release following 4 days of treatment with dihydralazine and urapidil in conscious dogs.
    Bacher S; Kraupp O; Beck A; Seitelberger R; Raberger G
    Cardiovasc Res; 1984 Feb; 18(2):67-74. PubMed ID: 6365312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dihydralazine and intracranial pressure. Risks in the treatment of patients with space-occupying, intracranial processes].
    Dahlerup B; Laursen J
    Ugeskr Laeger; 1987 Sep; 149(39):2589-91. PubMed ID: 3451489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.